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Abstract  
Introduction: The aim of this  study was to evaluate  the differences  in quality of life and 
psychosocial  stress parameters among patients with paroxysmal atrial  fibrillation (AF) and 
common forms of  atrioventricular  reentry  supraventricular  tachycardias  (SVTs).           
Methods and Results: The  total  study population  included  106 patients,  54 patients  with 
paroxysmal  AF  (32  males,  age  56.64±12.50  years)  and  52  with  SVTs  (25  males,  age 
40.46±14.96  years).  General  health  (p<0.01),  physical  function  (p=0.004),  role  emotion 
(p=0.002) and role physical (p<0.01) scores were lower in patients who suffered AF. SF-36 
physical and mental health summary measures were also significantly lower in the AF group 
compared to those in SVT group (p<0.01 and p=0.001, respectively). Lower SF-36 total score 
was observed in patients  with AF compared to those with SVTs (p<0.01).  Comparing the 
anxiety and depression scores all the values were higher in patients with AF. Higher STAI-
state  scores (p<0.01), STAI-trait  scores (p=0.039) and BDI scores (p=0.077) were seen in 
patients  who  suffered  AF  comparing  to  those  with  SVTs.                   
Conclusions Quality of life is significantly impaired and the level of anxiety is significantly 
higher in patients with AF comparing to those with common forms of SVTs.                 
Key  Words: Quality  of  life;  anxiety;  depression;  supraventricular  tachycardias;  atrial 
fibrillation.
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Introduction
Atrial Fibrillation (AF) is associated with a more severe impairment in quality of life (QoL) 
compared to general population [1]. AF imposes a significant psychosocial burden including 
depression and anxiety in approximately one third of patients [2]. Psychosocial stress can be 
elicited  by  AF  episodes  and  might  also  predispose  to  AF  initiation.  The  Framingham 
Offspring Study demonstrated that tension was an independent predictor of coronary heart 
disease, AF and mortality in men [3]. Several studies have demonstrated an improvement in 
QoL after left atrial catheter ablation of paroxysmal AF [4]. Atrioventricular nodal reentry 
tachycardia  (AVNRT)  and  atrioventricular  reentry  tachycardia  via  an  accessory  pathway 
(AVRT) are most common types of regular supraventricular tachycardias (SVTs). Due to the 
paroxysmal nature of the disease, the QoL is increasingly impaired over time [5,6]. SVTs are 
associated with anxiety in approximately 20% of patients [7]. Patients with SVTs treated with 
catheter ablation show significant improvement in physical, emotional and social indexes of 
their health-related QoL [8] and reduction in anxiety symptoms [9]. The aim of this study was 
to evaluate the differences in QoL and psychosocial stress parameters among patients with 
paroxysmal  AF  and  common  forms  of  SVT.                                     
Methods
Patients
The  study  population  consisted  of  consecutive  patients  with  symptomatic,  drug-refractory 
paroxysmal AF or symptomatic SVTs (AVNRT or AVRT) who referred for catheter ablation. 
Patients were classified as having paroxysmal AF according to the current guidelines [10]. 
Exclusion criteria were age <18years, presence of physical and/or mental insufficiency, left 
atrial  diameter  >50mm,  intracardiac  thrombi  documented  by  transesophageal 
echocardiography,  systolic  heart  failure  [left  ventricular  ejection  fraction  (LVEF)  <45%, 
NYHA III-IV], previous ablation for AF, persistent AF, inadequate follow-up and/or inability 
to provide informed consent. Demographic and clinical characteristics were collected from all 
patients. Transthoracic and transeshophageal echocardiography was performed in all subjects. 
LVEF were recorded in all patients. The study protocol was approved by the hospital's Ethics 
Committee  and written  informed consent  was obtained from all  patients.                 
Catheter  ablation  procedures                                        
Left atrial ablation for paroxysmal AF has been described in details elsewhere [11]. In brief, 
following the  transseptal  puncture,  the  three-dimensional  geometry  of  the  left  atrium was 
reconstructed using the CARTO 3 system (Biosense Webster, Inc., Diamond Bar, Calif., USA) 
for isolation of large atrial areas around both ipsilateral pulmonary veins with a 3.5-mm-tip 
ablation  catheter  (Thermo  Cool  Navi-Star,  Biosense  Webster,  Inc.,  Diamond  Bar,  Calif., 
USA). The power settings of the energy were individualized depending on the ablation sites. 
The end point  of  electrical  pulmonary  antral  isolation  was  the  absence  or  dissociation  of 
potentials  in  the  isolated  area  as  documented  with  the  circular  mapping  catheter  (Lasso, 
Biosense Webster, Inc., Diamond Bar, Calif., USA). The diagnosis of common type AVNRT 
and  AVRT was  established  using  common  criteria  and  diagnostic  manoeuvres  [12].  The 
ablation procedure for both SVTs has been previously described [13,14]. Left-sided accessory 
pathways were mapped using the transaotric approach via the femoral artery under systemic 
anticoagulation.  
Evaluation of QoL, anxiety and depression                                               
All patients were evaluated for QoL, anxiety and depression using specific questionnaires 24h 
before ablation. The SF-36 is a multipurpose, short-form health survey with 36 questions that 
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has been used widely to assess QoL in patients with cardiovascular disease [15]. It contains 
one  multi-item  scale  that  assesses  8  individuals  health  concepts:  physical  function,  role 
physical,  bodily  pain,  general  health,  vitality,  social  function,  role  emotional,  and mental 
health. Scores in each domain are standardized, ranging from 0 (worst health) to 100 (best 
health).  Physical and mental health summary measures were also assessed on a raw scale of 0 
to 100. The SF-36 total score was additionally calculated [16].                               
The State-Trait Anxiety Inventory (STAI) [17] was used to assess the current level of anxiety 
and  anxiety  predisposition.  The  STAI  comprises  of  two  separate  self-report  scales  each 
containing 20 questions, the first of which evaluates how the patients 'currently feel'  (state 
anxiety) while the second how they 'generally feel'  (trait  anxiety).  The total  score on both 
subscales ranges from 20 to 80, with higher scores indicating greater levels of anxiety. Scores 
of more than 40 on either subscale were used to indicate significant symptoms of anxiety, as 
mentioned  previously  [2,  18]  Both  scales  have  acceptable  internal  consistency,  with 
Cronbach's α coefficients of .92 and .90 for the state and trait scales, respectively. There is 
preliminary evidence showing that the reliability and the validity of the Greek translation of 
the STAI questionnaire are generally similar to those reported in the international literature 
[19].
Depression was diagnosed and its severity quantified using the Beck Depression Inventory 
(BDI) that is commonly used worldwide [20,21]. Various translations of the BDI have been 
published and this scale was proved to be psychometrically strong and appropriate for use. A 
Greek version has been applied to neurological patients [22]. The BDI consists of 21 items 
rated 0 to 3 depending on severity of symptoms. For each item, patients selected one answer 
that best described their condition during the last week preceding the evaluation.  Different 
questions  of  BDI  evaluate  mood,  pessimism,  past  failures,  loss  of  satisfaction,  guilt, 
punishment  feelings,  self-dislike,  suicidal  thoughts  or  wishes,  crying  irritability,  social 
isolation, perception of own body, difficulties at work, sleeplessness, loss of energy, loss of 
appetite,  body  mass  reduction  and  somatic  complaints.  Questions  1  to  13  evaluate 
psychosomatic  status,  while  questions  14  to  21  evaluate  mental  status.  The  overall  score 
indicates depression severity [23]. Depending on the population, different cut-off points may 
be  applicable.  The optimal  cut-off  points  of  Greek translation  of  BDI-21 for  clinical  and 
research use were 14/15 [22].                                                                           
 
Statistical  Analysis                                       
Continuous  variables  are  expressed as  mean ± SD. Categorical  variables  are  presented  as 
absolute numbers and frequencies. Comparisons of the continuous variables between study 
groups were performed using the Student's t-test. Comparison between categorical variables 
was  performed  using  the  Fisher's  exact  test.  Comparisons  of  the  continuous  variables 
regarding QoL parameters and psychosocial scores were performed using the paired t-test. All 
reported p values are based on two-sided tests and compared to a significance level of 0.05. 
The statistical  analysis  was performed using the SPSS software (version 17.0;  SPSS Inc., 
Chicago,  Illinois).                                                               
Results
The total study population included 106 patients, 54 patients with paroxysmal AF (32 males, 
age 56.64±12.50 years) and 52 with SVTs (25 males, age 40.46±14.96 years). Based on the 
electrophysiological findings, 31 out of 52 patients with SVT displayed AVNRT (59.61%), 
and 21 patients AVRT (40.38%). As shown in Table 1, patients with SVTs were younger 
(p<0.01) and displayed better left ventricular systolic function (p=0.015) comparing to those 
with AF. The duration of arrhythmic episodes were significantly longer in patients with AF in 
relation to those with SVTs (p<0.01). Patients with AF were more likely to receive class I and 
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class III antiarrhythmic drugs (p<0.01), while there were no significant differences regarding 
treatment with β-blockers between study groups.                                          
General  health  (p<0.01),  physical  function  (p=0.004),  role  emotion  (p=0.002)  and  role 
physical (p<0.01) scores were lower in patients who suffered AF. SF-36 physical and mental  
health summary measures were also significantly lower in the AF group compared to those in 
the SVT group (p<0.01 and p=0.001, respectively). Lower SF-36 total score was observed in 
patients with AF compared to those with SVTs (p<0.01).                                        
Anxiety scores were higher in patients with AF. Higher STAI-state scores (p<0.01) and STAI-
trait scores (p=0.039) were seen in patients who suffered AF comparing to those with SVTs. 
Depression scores (BDI) were also higher in patients with AF, but not statistically significant 
comparing  to  those  with  SVTs  (p=0.077).                                          
Table 1. Demographic, echocardiographic, QoL, anxiety and depression data between patients 
with AF and SVT.
AF: atrial fibrillation; AADs: antiarrhythmic drugs; SVT: supraventricular tachycardia; LVEF: left ventricular  
ejection fraction; AADs: antiarrhythmic drugs; SF-36: the Short-Form life survey-36 items; STAI: State-Trait  
Anxiety  Inventory;  BDI:  beck  depression  inventory.                                         
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Discussion
The main findings of the present study were: a) QoL parameters were significantly impaired in 
patients  with AF comparing  to  those suffering regular  SVTs;  and b)  the level  of anxiety, 
depicting psychosocial stress, was significantly higher in patients with AF in relation to those 
with  SVTs.                                              
Several  studies  have  investigated  the  relationship  between  psychological  variables  and 
arrhythmias. Patients diagnosed with AF experience more psychological distress than healthy 
individuals. It seems that AF symptom severity deteriorates QoL, and AF recurrence correlates 
with psychological distress in the form of depression and anxiety [24]. Anger, hostility and 
tension have been also recognized as risk factors for AF in males [3].  Tension in men and 
anxiety in both sexes were associated with increased mortality after risk factors for ischemic 
heart  disease  had  been  adjusted  [3].  Despite  the  fact  that  it  remains  unclear  how  acute 
psychological  disturbances  lead  to  AF,  some  possible  mechanisms  have  been  proposed. 
Previous studies have shown that chronic stress activates the inflammatory cascade [25-30]. 
The development and maintenance of AF have been associated with systemic inflammation 
[29-30]. Another potential pathogenetic link between psychological stress and AF recurrence 
is  the  activation  of  the  sympathetic  system [31-34].                                 
Patients with common regular SVTs (AVNRT or AVRT) are relatively young and otherwise 
healthy individuals. The hemodynamic consequences are similar in both of these SVTs, which 
include the shortening of the diastolic filling time of the ventricles, and varying degrees of 
impairment  of  synchronization  of  diastolic  filling  times  of  the  ventricles  and  ventricular 
contraction.  This may result  in palpitations,  dyspnea,  hyperventilation,  dizziness,  sweating, 
chest pain and anxiety [7]. Palpitations caused by these SVTs are associated with anxiety in 
approximately 20% of patients and may therefore be misdiagnosed as panic disorder [7]. Due 
to the paroxysmal character of the tachycardia, with sudden unexpected onset of symptoms, 
patients  are  limited  in  their  daily  life  concerning  work,  social  events  and  sports  [5,6]. 
Recurrent tachycardia with its unpredictable nature can have a significant impact on a person's 
entire life situation. The severity of arrhythmia symptoms, ranging from mild palpitations to 
complete syncope, may not only affect patients during the attack, but also influences their life 
situation between recurrences impacting quality of life. Frequent attacks are known to have 
considerable  effects  on  the  QoL  [5,6].  In  our  study,  the  significantly  longer  duration  of 
arrhythmic episodes in AF patients is possibly implicated in the deterioration of QoL as well 
as  in  the  induction  of  psychosocial  stress.  Furthermore,  patients  with  AF  were  more 
commonly under antiarrhythmic drug treatment, a fact that may also have an impact on QoL 
scores.
Limitations
This study has some potential limitations. First, a small number of patients were studied in 
both groups. Second, patients with AF were older, a fact that can cause sizeable differences in 
QoL and anxiety/depression scales. Third, the frequency and the intensity of the episodes were 
not  evaluated.  Finally,  data  regarding  QoL and  psychosocial  stress  parameters  following 
catheter  ablation  were  not  assessed.                                          
Conclusions
Assessing QoL status and psychosocial burden including depression and anxiety in patients 
with  AF and  SVTs  is  an  important  way  to  evaluate  and  describe  patients'  life  situation. 
Patients with AF manifested significantly lower QoL and higher anxiety levels compared to 
those  with  other  SVTs.  Arrhythmia  treatment  including  catheter  ablation  is  required  for 
patients  with  AF  displaying  poor  QoL  and  psychosocial  stress.                       
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